Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from In Good Company with Nicolai Tangen
See all episodes →
43%Venki Ramakrishnan: The Science and Hype of Living Longer
41%Eliot Higgins: How Bellingcat Hunts Down the Truth
39%Horizon Robotics CEO: Car Chips, Mind-Off Driving and China's Speed
Similar episodes from other shows
More like In Good Company with Nicolai Tangen →
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
ET@Davos: Corner Office Conversation with Nicolai Tangen
The $2 Trillion Mind | Nicolai Tangen
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.